0 items USD 0.00Search
Your search for "delveinsight cervical cancer global api manufacturers marketed phase iii drugs landscape 2016" gave back 48391 results.
The global Paclitaxel market size was valued at USD 121 million in 2023 and is forecast to a readjusted size of USD 205.3 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Summary Publisher Genitourinary Drugs market research report provides the newest industry data and industry future trends, allowing you to identify...
Catalog:
ICRW
August 2021
Price: USD 2,960.00
The global Paclitaxel market size was valued at US$ 115 million in 2023. With growing demand in downstream market, the Paclitaxel is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Globally Pharmaceutical markets are showing rapid growth and in coming years expected to evolve further in the field of research and development,...
Catalog:
IQ4I
May 2021
Price: USD 4,950.00
The global Cervical Cancer Drugs market size was valued at US$ 12890 million in 2023. With growing demand in downstream market, the Cervical Cancer...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
A molecular approach for diagnosing cervical cancer The global Cervical Cancer Molecular Diagnostics market was valued at US$ million in 2023 and is...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Cervical Cancer Treatment market size was valued at US$ 7213.9 million in 2023. With growing demand in downstream market, the Cervical...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Cervical Cancer Diagnostic Tests market size was valued at US$ 6706.3 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
